Publications
2023
Dwyer, A. R., Perez Kerkvliet, C., Truong, T. H., Hagen, K. M., Krutilina, R. I., Parke, D. N., Oakley, R. H., Liddle, C., Cidlowski, J. A., Seagroves, T. N., & Lange, C. A. (2023). Glucocorticoid Receptors Drive Breast Cancer Cell Migration and Metabolic Reprogramming via PDK4. Endocrinology, 164(7), bqad083.
2021
Kerkvliet, C. P., Truong, T. H., Ostrander, J. H., & Lange, C. A. (2021). Stress sensing within the breast tumor microenvironment: how glucocorticoid receptors live in the moment. Essays in biochemistry, 65(6), 971–983.
Truong, T.H., Benner, B., Hagen, K.M., Temiz, N.A., Perez Kerkvliet, C., Wang, Y., Cortes-Sanchez, E., Yang, C.-H., Trousdell, M.C., Pengo, T., Guillen, K.P., Welm, B.E., Dos Santos, C.O., Telang, S., Lange, C.A., and Ostrander, J.H. (2021). “PELP1/SRC-3 dependent regulation of metabolic kinases drives therapy resistant ER+ breast cancer.” Oncogene. 40(25): 4384-4397.
Kamaraju, S., Fowler, A. M., Weil, E., Wisinski, K. B., Truong, T. H., Lehr, M., Chaudhary, L. N., Cheng, Y. C., Chitambar, C. R., Rui, H., Yee, D., & Lange, C. (2021). Leveraging Antiprogestins in the Treatment of Metastatic Breast Cancer. Endocrinology, 162(8), bqab060.
Dwyer, A. R., Truong, T. H., Kerkvliet, C. P., Paul, K. V., Kabos, P., Sartorius, C. A., & Lange, C. A. (2021). Insulin receptor substrate-1 (IRS-1) mediates progesterone receptor-driven stemness and endocrine resistance in oestrogen receptor+ breast cancer. British journal of cancer, 124(1), 217–227.
2020
Dwyer, A. R., Truong, T. H., Ostrander, J. H., & Lange, C. A. (2020). 90 YEARS OF PROGESTERONE: Steroid receptors as MAPK signaling sensors in breast cancer: let the fates decide. Journal of molecular endocrinology, 65(1), T35–T48.
2019
Truong, T.H.*, Dwyer, A.R.*, Diep, C., Hu, H., Hagen, K.M., and Lange, C.A. (2019). “Phosphorylated progesterone receptor isoforms mediate opposing stem-like and proliferative breast cancer cell fates.” Endocrinology. 160(2), 430-446. *Equal contribution
2018
Truong, T. H., & Lange, C. A. (2018). Deciphering Steroid Receptor Crosstalk in Hormone-Driven Cancers. Endocrinology, 159(12), 3897–3907.
Truong, T. H., Lange, C. A., & Ostrander, J. H. (2018). Targeting steroid receptor co-activators to inhibit breast cancer stem cells. Oncoscience, 5(11-12), 281–282.
Truong, T.H., Hu, H., Temiz, N.A., Hagen, K.M., Girard, B.J., Brady, N.J., Schwertfeger, K.L., Lange, C.A., and Ostrander, J.H. (2018). “Cancer Stem Cell Phenotypes in ER+ Breast Cancer Models Are Promoted by PELP1/AIB1 Complexes.” Mol. Cancer Res. 16 (4) 707-719.
Leehy, K. A., Truong, T. H., Mauro, L. J., & Lange, C. A. (2018). Progesterone receptors (PR) mediate STAT actions: PR and prolactin receptor signaling crosstalk in breast cancer models. The Journal of steroid biochemistry and molecular biology, 176, 88–93.
2017
Knutson, T. P., Truong, T. H., Ma, S., Brady, N. J., Sullivan, M. E., Raj, G., Schwertfeger, K. L., & Lange, C. A. (2017). Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs. Journal of hematology & oncology, 10(1), 89.
2016
Truong, T.H., Ung, P.M., Palde, P.B., Paulsen, C.E., Schlessinger, A., and Carroll, K.S. (2016). “Molecular Basis for Redox Activation of Epidermal Growth Factor Receptor Kinase.” Cell Chem. Biol. 23 (7), 837-848.
2013
Truong, T. H., & Carroll, K. S. (2013). Redox regulation of protein kinases. Critical reviews in biochemistry and molecular biology, 48(4), 332–356.
2012
Truong, T. H., & Carroll, K. S. (2012). Redox regulation of epidermal growth factor receptor signaling through cysteine oxidation. Biochemistry, 51(50), 9954–9965.
2011
Paulsen, C.E., Truong, T.H., Garcia, F.J., Homann, A., Gupta V., Leonard, S.E., Carroll, K.S. (2011). “Peroxide-dependent sulfenylation of the EGFR catalytic site enhances kinase activity.” Nat. Chem. Biol. 8 (1), 57-64.
Truong, T. H., Garcia, F. J., Seo, Y. H., & Carroll, K. S. (2011). Isotope-coded chemical reporter and acid-cleavable affinity reagents for monitoring protein sulfenic acids. Bioorganic & medicinal chemistry letters, 21(17), 5015–5020.